XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.81

Change

-0.36 (-0.87)%

Market Cap

CAD 0.48B

Volume

6.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-1.54 (-1.12%)

CAD 17.23B
ZSP:CA BMO S&P 500

-0.96 (-1.13%)

CAD 16.16B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.51 (-0.85%)

CAD 10.90B
VUN:CA Vanguard US Total Market

-1.29 (-1.24%)

CAD 9.56B
XUS:CA iShares Core S&P 500 Index ETF

-0.56 (-1.16%)

CAD 7.36B
HXS:CA Global X S&P 500 Corporate Cla..

-0.95 (-1.19%)

CAD 4.06B
VSP:CA Vanguard S&P 500 CAD hedged

-0.84 (-0.90%)

CAD 3.52B
QUU:CA Mackenzie US Large Cap Equity ..

-2.53 (-1.13%)

CAD 3.25B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.64 (-1.27%)

CAD 3.07B
XUU:CA iShares Core S&P US Total Mark..

-0.71 (-1.24%)

CAD 3.07B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.11% 84% B 81% B-
Dividend Return 0.80% 28% F 24% F
Total Return 22.91% 86% B+ 80% B-
Trailing 12 Months  
Capital Gain 32.80% 66% D+ 79% B-
Dividend Return 1.23% 31% F 26% F
Total Return 34.03% 66% D+ 78% C+
Trailing 5 Years  
Capital Gain 100.05% 84% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.05% 73% C 83% B
Average Annual (5 Year Horizon)  
Capital Gain 13.79% N/A N/A 80% B-
Dividend Return 14.58% N/A N/A 78% C+
Total Return 0.80% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.48% N/A N/A 74% C
Risk Adjusted Return 100.72% N/A N/A 96% N/A
Market Capitalization 0.48B 53% F 59% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.